Will the return of the 2.3% excise tax change how medtech companies do business?
Most recently with Medtronic, Bryan C. Hanson has more than 20 years of experience in the medical device industry.
PwC’s Health Research Institute releases its annual Top Health Issues report.
This year the company exceeded its expectations, too.
The President’s actions (or distractions) may be detrimental to Western medical device companies.
Effectively leveraging the intellectual assets of your business requires a holistic approach to IP protection.
With the increase of diabetes prevalence in Asia and the rise of Asia’s middle classes, the demand for newer and better treatments will provide opportunities for Western medtech companies.
There really is not much rocket science involved when attempting to determine the odds of a device establishment being awarded a prized agency warning letter when the establishment is on the receiving end of sixteen Form 483 observations during an inspection.
There are usually only losers in patent litigation, so the best strategy is avoidance.
The doctor struggles to understand how the observation extracted from the warning letter referenced in this week’s guidance managed to rise to the level of a Form 483 Observation.